Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer

Koji Ando, Eiji Oki, Hiroshi Saeki, Zhao Yan, Yasuo Tsuda, Gen Hidaka, Yuta Kasagi, Hajime Otsu, Hiroyuki Kawano, Hiroyuki Kitao, Masaru Morita, Yoshihiko Maehara

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Immunohistochemistry staining of p53 is a cheap and simple method to detect aberrant function of p53. However, there are some discrepancies between the result of immunohistochemistry staining and mutation analysis. This study attempted to find a new definition of p53 staining by its staining pattern. Immunohistochemistry staining of p53 and TP53 gene mutation analysis were performed in 148 gastric cancer patients. Also SNP-CGH array analysis was conducted to four cases. Positive staining of p53 was observed in 88 (59.5%) tumors. Tumors with positive p53 staining showed malignant features compared to negative tumors. Mutation of TP53 gene was observed in 29 (19.6%) tumors with higher age and differentiated type. In positive p53 tumors, two types could be distinguished; aberrant type and scattered type. With comparison to TP53 gene mutation analysis, all the scattered type had wild-type TP53 gene (P = 0.0003). SNP-CGH array showed that scattered-type tumors had no change in the structure of chromosome 17. P53-scattered-type staining tumors may reflect a functionally active nonmutated TP53 gene. In interpretation of p53 immunohistochemistry staining, distinguishing p53-positive tumors by their staining pattern may be important in gastric cancer.

Original languageEnglish
Pages (from-to)75-83
Number of pages9
JournalCancer Medicine
Volume4
Issue number1
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Stomach Neoplasms
Immunohistochemistry
Staining and Labeling
p53 Genes
Neoplasms
Mutation
Single Nucleotide Polymorphism
Chromosomes, Human, Pair 17

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer. / Ando, Koji; Oki, Eiji; Saeki, Hiroshi; Yan, Zhao; Tsuda, Yasuo; Hidaka, Gen; Kasagi, Yuta; Otsu, Hajime; Kawano, Hiroyuki; Kitao, Hiroyuki; Morita, Masaru; Maehara, Yoshihiko.

In: Cancer Medicine, Vol. 4, No. 1, 01.01.2015, p. 75-83.

Research output: Contribution to journalArticle

Ando, K, Oki, E, Saeki, H, Yan, Z, Tsuda, Y, Hidaka, G, Kasagi, Y, Otsu, H, Kawano, H, Kitao, H, Morita, M & Maehara, Y 2015, 'Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer', Cancer Medicine, vol. 4, no. 1, pp. 75-83. https://doi.org/10.1002/cam4.346
Ando, Koji ; Oki, Eiji ; Saeki, Hiroshi ; Yan, Zhao ; Tsuda, Yasuo ; Hidaka, Gen ; Kasagi, Yuta ; Otsu, Hajime ; Kawano, Hiroyuki ; Kitao, Hiroyuki ; Morita, Masaru ; Maehara, Yoshihiko. / Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer. In: Cancer Medicine. 2015 ; Vol. 4, No. 1. pp. 75-83.
@article{32642558c4e14f2689074c1eab0d9619,
title = "Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer",
abstract = "Immunohistochemistry staining of p53 is a cheap and simple method to detect aberrant function of p53. However, there are some discrepancies between the result of immunohistochemistry staining and mutation analysis. This study attempted to find a new definition of p53 staining by its staining pattern. Immunohistochemistry staining of p53 and TP53 gene mutation analysis were performed in 148 gastric cancer patients. Also SNP-CGH array analysis was conducted to four cases. Positive staining of p53 was observed in 88 (59.5{\%}) tumors. Tumors with positive p53 staining showed malignant features compared to negative tumors. Mutation of TP53 gene was observed in 29 (19.6{\%}) tumors with higher age and differentiated type. In positive p53 tumors, two types could be distinguished; aberrant type and scattered type. With comparison to TP53 gene mutation analysis, all the scattered type had wild-type TP53 gene (P = 0.0003). SNP-CGH array showed that scattered-type tumors had no change in the structure of chromosome 17. P53-scattered-type staining tumors may reflect a functionally active nonmutated TP53 gene. In interpretation of p53 immunohistochemistry staining, distinguishing p53-positive tumors by their staining pattern may be important in gastric cancer.",
author = "Koji Ando and Eiji Oki and Hiroshi Saeki and Zhao Yan and Yasuo Tsuda and Gen Hidaka and Yuta Kasagi and Hajime Otsu and Hiroyuki Kawano and Hiroyuki Kitao and Masaru Morita and Yoshihiko Maehara",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/cam4.346",
language = "English",
volume = "4",
pages = "75--83",
journal = "Cancer Medicine",
issn = "2045-7634",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer

AU - Ando, Koji

AU - Oki, Eiji

AU - Saeki, Hiroshi

AU - Yan, Zhao

AU - Tsuda, Yasuo

AU - Hidaka, Gen

AU - Kasagi, Yuta

AU - Otsu, Hajime

AU - Kawano, Hiroyuki

AU - Kitao, Hiroyuki

AU - Morita, Masaru

AU - Maehara, Yoshihiko

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Immunohistochemistry staining of p53 is a cheap and simple method to detect aberrant function of p53. However, there are some discrepancies between the result of immunohistochemistry staining and mutation analysis. This study attempted to find a new definition of p53 staining by its staining pattern. Immunohistochemistry staining of p53 and TP53 gene mutation analysis were performed in 148 gastric cancer patients. Also SNP-CGH array analysis was conducted to four cases. Positive staining of p53 was observed in 88 (59.5%) tumors. Tumors with positive p53 staining showed malignant features compared to negative tumors. Mutation of TP53 gene was observed in 29 (19.6%) tumors with higher age and differentiated type. In positive p53 tumors, two types could be distinguished; aberrant type and scattered type. With comparison to TP53 gene mutation analysis, all the scattered type had wild-type TP53 gene (P = 0.0003). SNP-CGH array showed that scattered-type tumors had no change in the structure of chromosome 17. P53-scattered-type staining tumors may reflect a functionally active nonmutated TP53 gene. In interpretation of p53 immunohistochemistry staining, distinguishing p53-positive tumors by their staining pattern may be important in gastric cancer.

AB - Immunohistochemistry staining of p53 is a cheap and simple method to detect aberrant function of p53. However, there are some discrepancies between the result of immunohistochemistry staining and mutation analysis. This study attempted to find a new definition of p53 staining by its staining pattern. Immunohistochemistry staining of p53 and TP53 gene mutation analysis were performed in 148 gastric cancer patients. Also SNP-CGH array analysis was conducted to four cases. Positive staining of p53 was observed in 88 (59.5%) tumors. Tumors with positive p53 staining showed malignant features compared to negative tumors. Mutation of TP53 gene was observed in 29 (19.6%) tumors with higher age and differentiated type. In positive p53 tumors, two types could be distinguished; aberrant type and scattered type. With comparison to TP53 gene mutation analysis, all the scattered type had wild-type TP53 gene (P = 0.0003). SNP-CGH array showed that scattered-type tumors had no change in the structure of chromosome 17. P53-scattered-type staining tumors may reflect a functionally active nonmutated TP53 gene. In interpretation of p53 immunohistochemistry staining, distinguishing p53-positive tumors by their staining pattern may be important in gastric cancer.

UR - http://www.scopus.com/inward/record.url?scp=85005773758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85005773758&partnerID=8YFLogxK

U2 - 10.1002/cam4.346

DO - 10.1002/cam4.346

M3 - Article

C2 - 25354498

AN - SCOPUS:85005773758

VL - 4

SP - 75

EP - 83

JO - Cancer Medicine

JF - Cancer Medicine

SN - 2045-7634

IS - 1

ER -